-
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in the first half of 2024.
-
Tornado-damaged Pfizer plant in North Carolina restarts production
Pfizer had said most of the tornado damage was to a storage facility, rather than its medicine production area.
-
CDC recommends Pfizer maternal RSV vaccine to protect infants, paving way for fall availability
The CDC specifically recommended that expectant mothers 32 to 36 weeks into their pregnancy receive the shot, Pfizer’s Abrysvo, from September through January.
-
CDC recommends updated Covid shot for everyone ages 6 months and up
A panel of CDC advisers voted Tuesday to recommend updated Pfizer and Moderna coronavirus booster shots for everyone ages 6 months and up.
-
Tornado damages key Pfizer plant, sparking concerns of a drug shortage
A tornado has heavily damaged a major Pfizer pharmaceutical plant in North Carolina — the latest in a string of extreme weather events plaguing the U.S.
-
Pfizer RSV Vaccine That Protects Infants Could Receive FDA Approval This Summer
The single-dose RSV vaccine developed by Pfizer is administered to expectant mothers in the late second-to-third trimester of their pregnancy.
-
Pfizer Says Its Maternal RSV Vaccine Can Protect Newborns From Severe Illness
A new study suggests vaccinating pregnant women protects their newborns from the common but scary respiratory virus called RSV.
-
Pfizer Seeks to Expand Omicron Booster Authorization For Kids 5- to 11-Year-Olds
Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11.
-
Moderna Sues Pfizer, BioNTech Over Patent Behind COVID-19 Vaccine
The patent infringement lawsuits were filed in the U.S. District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany, according to a news release.
-
Moderna Sues Pfizer, BioNTech for Patent Infringement Over mRNA Tech Used to Develop COVID Vaccine
Moderna sued Pfizer and its German partner BioNTech on Friday, alleging that the two companies copied Moderna’s technology in developing their COVID-19 vaccine Comirnaty. Moderna said in a news release that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 covering its mRNA technology, which Moderna used to develop its own COVID-19 vaccine, Spikevax.
-
Pfizer COVID Pill Helped High-Risk Seniors But Showed No Benefit in Younger Adults: Study
The findings reflect the changing nature of the pandemic, in which the vast majority of people already have some protection against the virus due to vaccination or prior infection.
-
Pfizer Asks FDA to Authorize Its Updated COVID Booster Targeting Omicron
Pfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron strains: the BA.4 and BA.5 variants.
-
What the Lyme Disease Vaccine Could Mean for People Living With Long-Term Symptoms
Now entering late-stage clinical trials, the vaccine could be approved as soon as 2025.
-
Pharmacists Can Now Prescribe Drug That Curbs Symptoms Directly to COVID-19 Patients
The Pfizer pill, Paxlovid, is intended for people with COVID-19 who are more likely to become seriously ill. Previously only doctors could prescribe the drug
-
Pfizer Says Tweaked COVID-19 Shots Boost Omicron Protection
Pfizer says tweaking its COVID-19 vaccine to better target the omicron variant is safe and boosts protection.
-
FDA Advisers Endorse Moderna, Pfizer COVID-19 Shots for Kids Under 5
The FDA must still decide whether to take the recommendations and approve the COVID-19 vaccine for kids between six months and 5 years old.
-
FDA Advisers Endorse Moderna, Pfizer COVID-19 Shots for Kids as Young as 6 Months
COVID-19 shots for U.S. infants, toddlers and preschoolers moved a step closer Wednesday.